Login / Signup

Antibody response to SARS-CoV-2 mRNA BNT162b2 vaccine in kidney transplant recipients and in-centre and satellite centre haemodialysis patients.

Dominique BertrandMélanie HanoyStéphane EdetVeronique LeméeMouad HamzaouiCharlotte LaurentLebourg LudivineIsabelle EtienneMathilde LemoineDorian NezamSophie CandonJean-Christophe PlantierFrank Le RoyDominique Guerrot
Published in: Clinical kidney journal (2021)
Keyphrases
  • end stage renal disease
  • sars cov
  • chronic kidney disease
  • peritoneal dialysis
  • ejection fraction
  • newly diagnosed
  • prognostic factors
  • patient reported outcomes
  • binding protein
  • patient reported